Showing results (131-140 of 326) with videos related to
Sort By:
Pageof 33
Clinical Lymphoma, Myeloma & Leukemia|November 28, 2022
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple MyelomaDavid M Foureau, Barry A Paul, Fei Guo, et al.Plos One|September 26, 2013
Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myelomaBo Hu, Yu Chen, Saad Z Usmani, et al.The Lancet. Haematology|September 3, 2017
Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trialsManisha Bhutani, Qing Zhang, Reed Friend, et al.Journal of Strength and Conditioning Research|August 20, 2019
Precooling's Effect on American Football SkillsLibby J Bradley, Kevin C Miller, Brian W Wiese, et al.Journal of Sport Rehabilitation|November 23, 2011
Duration of electrically induced muscle cramp increased by increasing stimulation frequencyKevin C Miller, Kenneth L Knight, Steven R Wilding, et al.Sports Health|September 28, 2012
Exercise-associated muscle cramps: causes, treatment, and preventionKevin C Miller, Marcus S Stone, Kellie C Huxel, et al.Sports Health|January 16, 2014
Grade III Liver Laceration in a Female Volleyball PlayerAbby E Milton, Pamela J Hansen, Kevin C Miller, et al.Clinical Lymphoma, Myeloma & Leukemia|April 22, 2026
Diagnosis Disclosure and Related Illness Experience in Patients With Multiple Myeloma and Precursor Plasma Cell DisordersMaria A Malik, Akshay A Dalvi, Andriy Derkach, et al.Blood|June 8, 2012
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenanceSaad Z Usmani, Rachel Sexton, Antje Hoering, et al.Transplantation and Cellular Therapy|April 14, 2024
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell TherapyHamza Hashmi, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.Pageof 33